CLINICAL_TRIALS trial_result · 2012-06-04

Clinical Trial Update: A Study on the Effect of 2 Pen Devices on HbA1c [Phase 4]

Phase 4 trial evaluating two insulin pen devices on HbA1c in people with Type 1 diabetes; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED | Results posted: 2012-06-04